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Summary
 
To address the possible role of replicative senescence in human immunodeficiency virus (HIV)
infection, telomere length, telomerase activity, and in vitro replicative capacity were assessed in
peripheral blood T cells from HIV
 
1
 
 and HIV
 
2
 
 donors. Genetic and age-specific effects on
these parameters were controlled by studying HIV-discordant pairs of monozygotic twins. Telo-
mere terminal restriction fragment (TRF) lengths from CD4
 
1
 
 T cells of HIV
 
1
 
 donors were
significantly greater than those from HIV
 
2
 
 twins. In contrast, telomere lengths in CD8
 
1
 
 T cells
from HIV
 
1
 
 donors were shorter than in HIV
 
2
 
 donors. The in vitro replicative capacity of
CD4
 
1
 
 cells from HIV
 
1
 
 donors was equivalent to that of HIV
 
2
 
 donors in response to stimula-
tion through T cell receptor CD3 and CD28. Little or no telomerase activity was detected in
freshly isolated CD4
 
1
 
 or CD8
 
1
 
 lymphocytes from HIV
 
1
 
 or HIV
 
2
 
 donors, but was induced by
in vitro stimulation of both HIV
 
1
 
 and HIV
 
2
 
 donor cells. These results suggest that HIV infec-
tion is associated with alterations in the population dynamics of both CD4
 
1
 
 and CD8
 
1
 
 T cells,
but fail to provide evidence for clonal exhaustion or replicative senescence as a mechanism un-
derlying the decline in CD4
 
1
 
 T cells of HIV-infected donors.
 
A
 
progressive decrease in numbers of CD4
 
1
 
 T cells is a
prominent feature of HIV infection and AIDS that
correlates with progression of disease and susceptibility to
infection. It appears that excessive destruction of CD4
 
1
 
 T cells
occurs in HIV-1 (HIV) infection, and that an increased rate
of generation of CD4
 
1
 
 cells occurs concurrently, perhaps
reflecting compensatory mechanisms to maintain the popu-
lation of CD4
 
1
 
 cells (1). CD4
 
1
 
 T cell counts decrease with
progressive HIV infection, indicating that physiologic mech-
anisms of regeneration are insufficient to compensate ade-
quately for cell loss. It has also been suggested that in-
creased clonal expansion and possible clonal exhaustion of
CD8
 
1
 
 T cells occur in response to HIV infection (2, 3).
Among the factors that can influence replicative poten-
tial and clonal expansion, one mechanism that has received
considerable recent attention is the phenomenon of telo-
mere shortening during cell division (4–8). Observations in
somatic cells indicate that telomere shortening occurs with
each cell division. When telomere shortening has pro-
ceeded to some critical minimal length, cell senescence or
arrest of replication is observed, through mechanisms not
yet elucidated. Thus, in the absence of a compensatory mech-
anism to prevent or reverse replication-associated loss of
telomeric sequences, telomere shortening may contribute to
the finite replicative lifespan of normal somatic cells. A ri-
bonucleoprotein enzyme, telomerase, has the capacity to
add hexanucleotide telomeric repeats to chromosomes, thus
maintaining telomere length (9, 10). Therefore, it was of
interest to determine whether HIV infection results in al-
terations of telomere length within T cell subpopulations as
a reflection of the replicative history of these cells, and
whether the residual replicative potential of T cells is al-
tered in infected individuals.
 
Materials and Methods
 
Isolation and Fractionation of Peripheral Blood T Cells.
 
Subsets of
peripheral blood T cells were isolated by immunomagnetic bead-
ing as previously described (11).
 
Assay of Telomere Length.
 
Genomic DNA was isolated from
purified peripheral blood CD4
 
1
 
 and CD8
 
1
 
 T cells, digested with
HinfI and RsaI (Boehringer Mannheim, Mannheim, Germany),
and separated by electrophoresis on a 0.5% agarose gel. Gels were
dried, denatured, hybridized with a 
 
32
 
P end-labeled oligonucle-
otide (CCCTAA)
 
3
 
 probe, and the gels analyzed by PhosphorIm-
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ager (Molecular Dynamics, Sunnyvale, CA) as previously re-
ported (11).
 
PCR-based Telomerase Assay.
 
The telomerase assay used here
was modified from the telomeric repeats amplification protocol
(TRAP)
 
1
 
 described previously (12). Cell extracts were prepared
in CHAPS lysis buffer, and the telomerase assay and PCR ampli-
fication steps were carried out in separate tubes with different
buffers to improve the telomerase efficiency. Telomerase prod-
ucts equivalent to the extracts from 10
 
4
 
 cells were used for PCR
with 27 cycles of amplification. The amplified products were sep-
arated on a 12% acrylamide gel (NOVEX, San Diego, CA) and
the results analyzed on a PhosphorImager (Molecular Dynamics)
or by exposure to radiographic film. To estimate the activity of
telomerase, serial dilutions of cell extracts were employed, and an
internal standard was included to allow quantitation of PCR by
competition in selected experiments. Controls for the TRAP as-
say included RNase treatment of cell extracts, single primer (Ts
or Cx alone), and water as template for PCR.
 
In Vitro Stimulation.
 
CD4
 
1
 
 T cells were repeatedly stimulated
with immobilized anti-CD3 and anti-CD28 as previously de-
scribed (11). Population expansion was measured until cell cul-
tures were unresponsive to further stimulation.
 
Results
 
Telomere Length in CD4
 
1
 
 and CD8
 
1
 
 T Cells from HIV-
infected and Uninfected Twins.
 
To control for known genetic
(13) and age-specific (4–8) effects on telomere length and
replicative potential, peripheral blood T cells were analyzed
from seven pairs of genetically identical monozygotic twins
who were discordant for HIV infection (Table 1). Total
CD4
 
1
 
 counts ranged from 92 to 562 cells/ml in HIV
 
1
 
 do-
nors, and 500 to 1,516 in their HIV
 
2
 
 twins. CD8 counts
ranged from 501 to 1,131 in HIV
 
1
 
 donors, and from 378
to 786 in HIV
 
2
 
 donors.
If, as has been suggested (14, 15), peripheral blood
CD4
 
1
 
 cells from HIV-positive donors undergo increased
cell division, this difference might be reflected in shorten-
ing of telomeres from infected donors when compared with
uninfected twins. Representative telomere terminal restric-
 
1
 
Abbreviations used in this paper:
 
 mpd, mean population doublings; TRAP,
telomeric repeats amplification protocol; TRF, terminal restriction frag-
ment.
 
Table 1.
 
Donor Status
 
Twin Pair
CD4 count
 
*
 
%CD45RA/
CD4
 
1
 
‡
 
CD8 count
 
*
 
Age
HIV
diagnosed
Current
clinical status
Antiviral
therapy HIV
 
1
 
HIV
 
2
 
HIV
 
1
 
HIV
 
2
 
HIV
 
1
 
HIV
 
2
 
yr
 
1 298 1516 31.7 24.6 1131 786 54 01/89 Pres. PCp (1990)
 
§
 
AZT, ddI, D4T
2 464 658 27.7 22.5 501 415 31 10/93 Asymptomatic AZT
3 120 500 14.7 5.9 519 378 44 06/88 Chronic Hepatitis B AZT, 3TC
4 124 712 42.5 24.7 591 642 30 05/90 Asymptomatic ddC, 3TC
5 355 1037 51.9 57.3 709 499 29 12/92 Asymptomatic AZT
6 92 605 51.2 26.9 771 546 54 1989 Asymptomatic None
7 562 1344 57.7 52.2 1111 359 45 02/90 Asymptomatic AZT
 
*
 
Number of cells/mm
 
3
 
 of peripheral blood.
 
‡
 
Percent of CD4
 
1
 
 T cells which are CD5RA positive and CD45RO negative.
 
§
 
Presumed 
 
Pneumocystis corinii
 
 pneumonia noted in 1990, but asymptomatic at the time of apheresis.
Figure 1. Telomere length in
CD41 and CD81 T cells. Ge-
nomic DNA was isolated from
purified peripheral blood CD41
and CD81 T cells, digested, sepa-
rated by electrophoresis, and the
dried and denatured gel was hy-
bridized with a 32P end-labeled
oligonucleotide (CCCTAA)3 probe.
Hybridized gels were subjected
to PhosphorImager analysis. 
1383
 
Palmer et al.
 
tion fragment (TRF) length analysis of CD4
 
1
 
 and CD8
 
1
 
T cells from HIV-positive and negative monozygotic twins
is presented in Fig. 1. When comparisons of mean TRF
length were made within each twin pair, it was observed
that TRF length in CD4
 
1
 
 cells on average was significantly
greater in the infected than in the uninfected twins (mean
difference 1.2 
 
6
 
 0.4 kb) (Fig. 2, 
 
A
 
 and 
 
C
 
). When TRF
length was analyzed in CD8
 
1
 
 populations from HIV-dis-
cordant twins, the opposite pattern was observed, with
TRF length in CD8
 
1
 
 cells shorter in HIV-infected twins
than in uninfected twins (mean difference 1.1 
 
6
 
 0.3 kb)
(Fig. 2, 
 
B
 
 and 
 
C
 
). In HIV-uninfected donors, TRF length
in CD8
 
1
 
 T cells tended to be longer than in CD4
 
1
 
 cells
from the same individual (mean difference 1.2 
 
6
 
 0.7 kb);
whereas in HIV-infected twins, TRF length was greater in
CD4
 
1
 
 cells (mean difference 0.9 
 
6
 
 0.4 kb).
 
Telomerase Activity in CD4
 
1
 
 and CD8
 
1
 
 T Cells from HIV-
infected and Uninfected Twins.
 
Two opposing factors are
known to contribute to telomere length: the shortening of
telomeres that occurs with cell division and chromosomal
replication, and the extension of telomeres mediated by
telomerase. To determine whether the TRF length of CD4
 
1
 
T cells from HIV-infected donors might be influenced by
Figure 2. Telomere length in CD41 and CD81 T cells from HIV-pos-
itive and -negative twins. TRF analysis was carried out as described in
Fig. 1, and mean TRF length calculated. (A) TRF length is shown for
CD41 T cells from HIV-negative (stippled bars) and HIV-positive (closed
bars) twin donors. (B) TRF length is shown for CD81 T cells from HIV-
negative (stippled bars) and HIV-positive (closed bars) twin donors. (C) The
difference in TRF length for HIV-positive and HIV-negative twin do-
nors is shown for CD41 (closed bar) and CD81 (stippled bar) T cells. Posi-
tive values indicate TRF length that is greater in the HIV-positive twin, and
negative values indicate TRF length that is greater in the HIV-negative
twin.
telomerase activity, telomerase was measured using the
PCR-amplified TRAP assay. Telomerase activity was low
or undetectable in ex vivo isolated CD41 or CD81 cells
from a separate panel of 15 (non-twin) HIV-positive donors
analyzed or from HIV-negative controls (Fig. 3). Stimula-
tion of CD41 T cells from HIV-negative donors with anti-
CD3 and anti-CD28 induced vigorous telomerase activity,
consistent with previous studies (12, 16); and T cells from
HIV-positive donors exhibited similar levels of telomerase
activity after stimulation (Fig. 3).
Replicative Potential of CD41 T Cells from HIV-infected and
Uninfected Twins. To determine more directly whether
the progressive decrease in CD41 cell counts during HIV
infection reflects replicative senescence, CD41 T cells were
stimulated repeatedly with immobilized anti-CD3 and anti-
CD28 antibodies, and replicative capacity was measured as
the mean number of population doublings (mpd) achieved
before proliferative response ceased (Fig. 4). When CD41
cells from five sets of discordant twins were compared,
there was no significant difference in the capacity for in
vitro cell division exhibited by HIV-positive and negative
donors (16.6 6 2.2 mpd for HIV-positive donors and 18.2 6
2.1 mpd for HIV-negative donors).1384 Telomere Length, Telomerase, and Replicative Potential in HIV Infection
Discussion
The population dynamics of T cell subsets from HIV-
infected patients are of considerable interest in efforts to
understand the pathogenesis and natural history of AIDS
and to design therapeutic intervention. A consistent feature
of HIV infection is the progressive decrease in CD41 T
cells that appears to correlate strongly with immune defi-
ciency and susceptibility to opportunistic infection (1). Sev-
eral  lines of experimental evidence have suggested that
there is increased destruction of CD41 T cells in HIV in-
fection, and that there is an increased production rate of
CD41 T cells in HIV-infected individuals, possibly in re-
sponse to this increased destruction (14, 15). These previ-
ous reports suggested that the ultimate decrease in CD41 T
cell levels observed in AIDS might result, at least in part,
from exhaustion of the capacity to generate CD41 cells
(17). Since the demonstration 35 years ago that human fi-
broblasts, a model of normal somatic cells, have a finite ca-
pacity for cell division measured in vitro (18), numerous
studies have confirmed this observation for cell populations
including human T cells. Such findings are consistent with
the possibility that a form of clonal exhaustion or senes-
cence might contribute to the immune deficiency seen in
AIDS.
The studies reported here have assessed the replicative
history and potential of T cells from HIV-infected donors by
evaluating several parameters. Telomere length in normal
human somatic cells, including T lymphocytes, decreases
with cell replication in vitro, on average by 50–200 bp per
population doubling (4–8, 11). A mechanistic explanation
for this shortening has been proposed, based on the primer
requirement for DNA polymerases and the consequent in-
ability to completely replicate chromosomal termini during
cellular S phase. In vivo, telomere length decreases with
age of the donor, suggesting that a similar process occurs
with aging. These observations have led to a model in
which telomere shortening contributes to the finite replica-
tive lifespan of normal somatic cells, with senescence oc-
curring when telomere length reaches some critical mini-
mum that is required for cell replication. Measurement of
telomere length has been used to analyze the replicative
history of cell populations, an approach that has been ap-
plied to analysis of human T cells from healthy uninfected
donors. The finding that TRF from CD41 cells of memory
(CD45RO) phenotype are on average 1.4 kb shorter than
TRF from naive (CD45RA) CD41 cells, and that memory
cells have less residual replicative potential than naive cells
under defined conditions, has been used as the basis for
speculation concerning the dynamics of clonal expansion
relating these two populations (11).
In the studies reported here, it was found that CD81 T
cells from infected donors had TRF that were shorter than
those of uninfected donors. Analysis of telomere length has
recently been applied to subsets of human CD81 T cells.
The CD282 subset of CD81 T cells from healthy unin-
fected donors was characterized as a clonally expanded sub-
set and was reported to have TRF that were significantly
shorter than TRF from CD281CD81 cells of the same do-
nor (19). Consistent with this finding, it was recently re-
ported that telomere length was reduced in the expanded
CD282 subset of CD81 cells from HIV-infected patients
(20). The possibility that this difference is related to a func-
tional compromise of CD81 cells in HIV patients deserves
further attention.
Previous reports have suggested that in HIV-positive do-
nors, increased proliferation of CD41 T cells may occur in
vivo (14). Were this the case, it might have been expected
that CD41 cells from HIV-positive twins would, as a cor-
relate of increased clonal expansion, exhibit shorter telo-
meres than cells from uninfected genetically identical twins.
However, the studies reported here demonstrated that, in
contrast with what was observed for CD81 cells, CD41 cells
from HIV-positive donors in fact had TRF significantly
longer than those of uninfected twins. Limitations in the
Figure 3. Telomerase activity in T cells from HIV-positive and HIV-
negative donors. CD41 and CD81 T cells were isolated from HIV-posi-
tive and HIV-negative donors by negative selection. Telomerase activity
was assayed in freshly isolated cells and after in vitro stimulation with anti-
CD3 and anti-CD28. T cells were stimulated for 5 d with a combination
of bead-bound anti-CD3 and CD28 mAbs. Results shown are representa-
tive of 15 HIV1 donors and their HIV2 controls. 293 is a transformed hu-
man kidney cell line that expresses high levels of telomerase and is used
here as a positive control. HUVEC are normal epithelial cells isolated
from human umbilical vein used here as a negative control.1385 Palmer et al.
amount of blood that was available from donors in the
present study prevented direct analysis of telomere length
in fractionated CD45RA1 and CD45RO1 subsets of CD41
cells. However, there was no preferential decrease in the
fraction of CD45RA1 (naive) CD41 T cells in HIV-infected
twins in the present study, and, therefore, the differences in
telomere length observed between HIV1 and HIV2 twins
did not correlate with differences in the proportions of
these subpopulations. These observations might be inter-
preted to indicate that, in HIV-infected donors, CD41 cells
were on average derived from stem cells by a path that in-
volved fewer cell divisions than occur in uninfected indi-
viduals, resulting in telomere preservation. For example,
this might occur if destruction of CD41 cells resulted in re-
generation from a pool of stem cells which themselves had
retained longer telomeres. Alternatively, telomere shorten-
ing may be uncoupled from cell division in CD41 cells
from HIV-infected donors, for example, by a mechanism
such as the induction of telomerase. The present study pro-
vided no evidence that in vivo telomerase activity contrib-
utes to telomere length differences associated with HIV in-
fection, although it cannot be excluded that telomerase
activity in sites other than peripheral blood, or at levels not
detected by the assay employed, plays a role. Finally, the
possibility that HIV infection selectively destroys CD41 T
cells with shorter telomeres cannot be excluded. These
findings, together with the demonstration that the in vitro
replicative potential of CD41 cells from AIDS patients was
not diminished relative to that of uninfected twins, suggest
that HIV infection may be associated with alterations in the
population dynamics of both CD41 and CD81 T cells, but
that clonal exhaustion or senscence is not a dominant factor
in the progressive loss of CD41 cells in patients with AIDS.
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Figure 4. Replicative potential
of CD41 T cells from HIV-posi-
tive and HIV-negative donors.
CD41 T cells were repeatedly
stimulated with immobilized
anti-CD3 and anti-CD28. Popu-
lation expansion was measured
until cell cultures were unrespon-
sive to further stimulation. The
data shown are representative of
five twin pairs studied.1386 Telomere Length, Telomerase, and Replicative Potential in HIV Infection
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